Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 480

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 480
---
 The information provided on, or accessible through, our website, other than the copies of the documents listed or referenced below that have been or will be filed with the SEC, is not part of this information statement, and therefore is not incorporated herein by reference.

<div align='center'>277</div>

#### TABLE OF CONTENTS
We undertake to provide without charge to each person to whom a copy of this information statement has been delivered, upon written or oral request, by first-class mail or other equally prompt means within one business day of receipt of such request, a copy of this information statement. You may request a copy of these filings by writing or telephoning us at the following address:

<div align='center'>Channel Therapeutics Corporation

4400 Route 9 South, Suite 1000

Freehold, NJ 07728

(877) 265-8266</div>

Ligand and LNHC have supplied, and we have not independently verified, the information in this information statement relating to Ligand and LNHC.

Stockholders should not rely on information that purports to be made by or on behalf of us other than that contained in this information statement. We have not authorized anyone to provide information on behalf of us that is different from that contained in this information statement. This information statement is dated    , 2025. No assumption should be made that the information contained in this information statement is accurate as of any date other than that date, and the mailing of this information statement will not create any implication to the contrary.

<div align='center'>278</div>

TABLE OF CONTENTS

CHANNEL THERAPEUTICS CORPORATION INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

|                                                                        |     | Page |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 688) |     | F-2  |
| Audited Financial Statements                                           |     |      |
| Consolidated Balance Sheets                                            |     | F-3  |
| Consolidated Statements of Operations                                  |     | F-4  |
| Consolidated Statements of Changes in Stockholders’ Equity (Deficit)   |     | F-6  |
| Consolidated Statements of Cash Flows                                  |     | F-7  |
| Notes to the Consolidated Financial Statements                         |     | F-8  |

F-1

#### TABLE OF CONTENTS

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of